<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05125653</url>
  </required_header>
  <id_info>
    <org_study_id>AinShamsSurg2</org_study_id>
    <nct_id>NCT05125653</nct_id>
  </id_info>
  <brief_title>Indocyanine Green Fluorescent Cholangiography and Intraoperative Angiography With Laparoscopic Cholecystectomy</brief_title>
  <official_title>Indocyanine Green Fluorescent Cholangiography and Intraoperative Angiography With Laparoscopic Cholecystectomy, a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This was a double blinded, randomized, controlled trial involved patients underwent&#xD;
      laparoscopic cholecystectomy&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A double blinded, randomized, controlled trial involved patients underwent laparoscopic&#xD;
      cholecystectomy in Ain-Shams University Specialized Hospital in the period from January 2020&#xD;
      till July 2021. Group A (n=60) underwent laparoscopic cholecystectomy using the usual white&#xD;
      light, Group B (n=58) underwent laparoscopic cholecystectomy with ICG florescence&#xD;
      cholangiography and intra-operative ICG florescence arteriography.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Actual">July 1, 2021</completion_date>
  <primary_completion_date type="Actual">July 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>2 arms, randomized, double blinded</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual identification of the biliary tree</measure>
    <time_frame>during the procedure</time_frame>
    <description>To measure the % of patients in which we can identify visually the extra hepatic biliary system (the CD, CBD, CHD, and any possible anomalies present), during LC.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual identification of the cystic artery</measure>
    <time_frame>during the procedure</time_frame>
    <description>To measure the % of patients in which we can identify visually the cystic artery, during LC.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual identification of injuries</measure>
    <time_frame>during and imediatly after the procedure (24 hours)</time_frame>
    <description>To detect of incidence rate of biliary or vascular injury, visually or clinically, resulted from miss identification of the structures.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare operative time</measure>
    <time_frame>during the procedure</time_frame>
    <description>To compare the operative time in (minutes)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>compare blood loss</measure>
    <time_frame>during the procedure</time_frame>
    <description>to compare the operative blood loss (in cc)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>compare blood loss in cc</measure>
    <time_frame>during the procedure</time_frame>
    <description>to compare the blood loss (in cc)) between the two groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients of ICG adverse reactions</measure>
    <time_frame>Within 24 hour of the procedure</time_frame>
    <description>To measure % of patients suffering off reactions related to the use of ICG (by vital data assessment, monitor patients' complaints, etc..)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">118</enrollment>
  <condition>Cholecystitis</condition>
  <condition>Chronic Calculous Cholecystitis</condition>
  <condition>Acute Calculous Cholecystitis</condition>
  <arm_group>
    <arm_group_label>NIR/ICG Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Indocyanine Green Fluorescent Cholangiography and Intraoperative Angiography will be done during the Laparoscopic Cholecystectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>WL Arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>conventional white light was used for Laparoscopic Cholecystectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Indocyanine Green Fluorescent Laparoscopic Cholangiography</intervention_name>
    <description>Indocyanine Green Fluorescent Cholangiography</description>
    <arm_group_label>NIR/ICG Arm</arm_group_label>
    <other_name>Indocyanine Green Fluorescent LaparoscopicCholangiography</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>White Light</intervention_name>
    <description>Performing the laparoscopic cholecystectomy and identifying the biliary structures under the conventional white light</description>
    <arm_group_label>WL Arm</arm_group_label>
    <other_name>WL</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adults (from 18 to 75 years old)&#xD;
&#xD;
          -  suffering from a gall bladder disease&#xD;
&#xD;
          -  with valid indication for laparoscopic cholecystectomy (e.g., calculus gall bladder&#xD;
             with cholecystitis)&#xD;
&#xD;
          -  accepted to participate in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with history of previous biliary surgery&#xD;
&#xD;
          -  Patients with abdominal malignancy&#xD;
&#xD;
          -  Patients with advanced chronic liver disease&#xD;
&#xD;
          -  pregnant women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>M Abd-erRazik, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Ain Shams University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ain Shams University Hospitals - AUSH</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 4, 2021</study_first_submitted>
  <study_first_submitted_qc>November 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2021</study_first_posted>
  <last_update_submitted>November 6, 2021</last_update_submitted>
  <last_update_submitted_qc>November 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Mohammad Ahmad Abd-erRazik</investigator_full_name>
    <investigator_title>Lecturer of General Surgery</investigator_title>
  </responsible_party>
  <keyword>Laparoscopic Cholecystectomy</keyword>
  <keyword>Indocyanine Green Fluorescent Cholangiography</keyword>
  <keyword>Indocyanine Green Fluorescent Angiography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholecystitis</mesh_term>
    <mesh_term>Acalculous Cholecystitis</mesh_term>
    <mesh_term>Cholecystitis, Acute</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

